Jamieson Wellness Inc., the Calgary‑based maker of vitamins and nutritional supplements, has hired Bank of Montreal and Canaccord Genuity to evaluate a possible sale. The move signals that the company’s board is actively weighing strategic alternatives after a period of steady revenue growth. Investors will watch the process for clues on valuation and potential buyer interest.

The consumer health market has seen a wave of consolidations, with larger players snapping up niche brands to broaden distribution channels. Private‑equity firms have shown appetite for Canadian supplement companies, attracted by stable cash flows and growing wellness trends. Jamieson’s decision to test the waters aligns with this broader sector dynamic.

With BMO and Canaccord leading the mandate, a confidential auction could soon commence, inviting interest from strategic buyers or private‑equity sponsors. Should a deal materialize, shareholders may receive a premium over the current share price, while the company could benefit from access to additional capital for product expansion. The outcome will reshape its ownership structure.

By opening a sale process, Jamieson Wellness places itself at the centre of a likely reshuffle in Canada’s health‑product sector, where scale and distribution are increasingly prized. Market participants will gauge the price range and terms as a barometer for the sector’s valuation. The transaction, if completed, will redefine the company’s growth trajectory.